Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Rhinology ; 58(5): 418-429, 2020 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-32500870

RESUMEN

BACKGROUND: Progressive advances in proteomic technology has improved our understanding of the chronic rhinosinusitis (CRS) pathogenesis and endotypes. This scoping review aims to present a comprehensive and descriptive analysis of nasal mucosa and mucus proteome of CRS patients. METHODOLOGY: Studies investigating the proteome of nasal mucosa and mucus from healthy and CRS patients via mass spectrometry were included. Critical appraisal of methodological quality was conducted with extraction of protein lists. Gene set enrichment analysis (GSEA) was performed on studies including CRS patients. RESULTS: 2962 proteins were identified in the 21 studies included in this review. Eleven studies investigated the nasal mucus proteome and ten studies investigated the nasal mucosa proteome. Studies demonstrated heterogeneity in patients, sampling and mass spectrometry methodology. Samples from CRS patients suggested a trend in enrichment of immune system and programmed cell death pathways. Increased expression of proteins involved in cellular components including the cytoskeleton and adherens junctions was also present in CRS. CONCLUSIONS: Alterations in the healthy sinonasal proteome may lead to the increased immunological, metabolic and tissue remodeling processes observed in CRS. However, it is difficult to draw significant conclusions from the GSEA due to the heterogeneity present in the limited literature available. These findings allow us to direct further research to better understand CRS pathogenesis and its endotypes.


Asunto(s)
Pólipos Nasales , Proteómica , Rinitis , Sinusitis , Enfermedad Crónica , Humanos , Moco , Mucosa Nasal/patología , Pólipos Nasales/genética , Pólipos Nasales/patología , Rinitis/genética , Rinitis/patología , Sinusitis/genética , Sinusitis/patología
2.
Clin Otolaryngol ; 43(3): 812-822, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29247602

RESUMEN

BACKGROUND: Simulation provides a safe and effective opportunity to develop surgical skills. A variety of endoscopic sinus surgery (ESS) simulators has been described in the literature. Validation of these simulators allows for effective utilisation in training. OBJECTIVE OF REVIEW: To conduct a systematic review of the published literature to analyse the evidence for validated ESS simulation. SEARCH STRATEGY: Pubmed, Embase, Cochrane and Cinahl were searched from inception of the databases to 11 January 2017. EVALUATION METHOD: Twelve thousand five hundred and sixteen articles were retrieved of which 10 112 were screened following the removal of duplicates. Thirty-eight full-text articles were reviewed after meeting search criteria. Evidence of face, content, construct, discriminant and predictive validity was extracted. RESULTS: Twenty articles were included in the analysis describing 12 ESS simulators. Eleven of these simulators had undergone validation: 3 virtual reality, 7 physical bench models and 1 cadaveric simulator. Seven of the simulators were shown to have face validity, 7 had construct validity and 1 had predictive validity. None of the simulators demonstrated discriminate validity. CONCLUSION: This systematic review demonstrates that a number of ESS simulators have been comprehensively validated. Many of the validation processes, however, lack standardisation in outcome reporting, thus limiting a meta-analysis comparison between simulators.


Asunto(s)
Endoscopía/educación , Senos Paranasales/cirugía , Entrenamiento Simulado , Competencia Clínica , Humanos
3.
Hong Kong Med J ; 21(3): 224-31, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25999031

RESUMEN

OBJECTIVES: To review the short-term outcome of endoscopic resection of superficial upper gastro-intestinal lesions in Hong Kong. DESIGN: Historical cohort study. SETTING: All Hospital Authority hospitals in Hong Kong. PATIENTS: This was a multicentre retrospective study of all patients who underwent endoscopic resection of superficial upper gastro-intestinal lesions between January 2010 and June 2013 in all government-funded hospitals in Hong Kong. MAIN OUTCOME MEASURES: Indication of the procedures, peri-procedural and procedural parameters, oncological outcomes, morbidity, and mortality. RESULTS: During the study period, 187 lesions in 168 patients were resected. Endoscopic mucosal resection was performed in 34 (18.2%) lesions and endoscopic submucosal dissection in 153 (81.8%) lesions. The mean size of the lesions was 2.6 (standard deviation, 1.8) cm. The 30-day morbidity rate was 14.4%, and perforations and severe bleeding occurred in 4.3% and 3.2% of the patients, respectively. Among patients who had dysplasia or carcinoma, R0 resection was achieved in 78% and the piecemeal resection rate was 11.8%. Lateral margin involvement was 14% and vertical margin involvement was 8%. Local recurrence occurred in 9% of patients and 15% had residual disease. The 2-year overall survival rate and disease-specific survival rate was 90.6% and 100%, respectively. CONCLUSION: Endoscopic mucosal resection and endoscopic submucosal dissection were introduced in low-to-moderate-volume hospitals with acceptable morbidity rates. The short-term survival was excellent. However, other oncological outcomes were higher than those observed in high-volume centres and more secondary procedures were required.


Asunto(s)
Adenoma/cirugía , Carcinoma/cirugía , Neoplasias Duodenales/cirugía , Neoplasias Esofágicas/cirugía , Perforación Intestinal/etiología , Hemorragia Posoperatoria/etiología , Neoplasias Gástricas/cirugía , Adenoma/patología , Anciano , Pérdida de Sangre Quirúrgica , Carcinoma/patología , Disección/efectos adversos , Neoplasias Duodenales/patología , Endoscopía Gastrointestinal , Neoplasias Esofágicas/patología , Femenino , Mucosa Gástrica/cirugía , Hong Kong , Humanos , Mucosa Intestinal/cirugía , Masculino , Auditoría Médica , Persona de Mediana Edad , Neoplasia Residual , Estudios Retrospectivos , Neoplasias Gástricas/patología , Tasa de Supervivencia , Resultado del Tratamiento
4.
J Appl Microbiol ; 104(5): 1354-62, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18266705

RESUMEN

AIMS: To develop an efficient and facile expression system supply of high purity and stable activity of rFip-fve for oral administration, medicinal study and applications. METHODS AND RESULTS: A recombinant virus that contained the chimera gene, encoding a bombyxin signal peptide sequence fused to a Fip-fve-6His sequence, was constructed. The rFip-fve was purified from the supernatant of the infected Sf21 cells using a nickel-chelated affinity column, and was verified by Western blot and MALDI-MS (matrix-assisted laser desorption ionization mass spectrometry) analyses. Results showed that a glycosylated mature rFip-fve was produced and secreted into the infected cell supernatant. The immunomodulatory activity of rFip-fve was evaluated by measuring the amount of interleukin-2 released from murine splenocytes. CONCLUSIONS: A reliable scheme to express and purify active rFip-fve in a baculovirus/insect cell system for medicinal applications and genetic study is a feasible means of solving potential problems related to the production and activity of rFip-fve protein. SIGNIFICANCE AND IMPACT OF THE STUDY: The rFip-fve expressed in insect cells was processed and modified in a manner more similar to that of its native counterpart than that in bacterial cells. Therefore, the potential applications of rFip-fve that is generated in Sf21 cells can be more effectively evaluated that produced in Escherichia coli.


Asunto(s)
Baculoviridae/fisiología , Proteínas Fúngicas/aislamiento & purificación , Factores Inmunológicos/aislamiento & purificación , Microbiología Industrial , Lectinas/aislamiento & purificación , Animales , Reactores Biológicos , Línea Celular , Células Cultivadas , Escherichia coli , Proteínas Fúngicas/farmacología , Factores Inmunológicos/farmacología , Interleucina-2/biosíntesis , Lectinas/farmacología , Ratones , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/farmacología , Bazo/efectos de los fármacos , Bazo/inmunología , Spodoptera/virología
5.
J Laryngol Otol ; 132(4): 299-313, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28502256

RESUMEN

BACKGROUND: Recurrent oropharyngeal squamous cell carcinoma causes great morbidity and mortality. This systematic review analyses survival outcomes following salvage surgery for recurrent oropharyngeal squamous cell carcinoma. METHODS: A comprehensive search of various electronic databases was conducted. Studies included patients with recurrent or residual oropharyngeal squamous cell carcinoma treated with salvage surgery. Primary outcomes were survival rates following salvage surgery. Secondary outcomes included time to recurrence, staging at time of recurrence, post-operative complications, and factors associated with mortality and recurrence. Methodological appraisal and data extraction were conducted as per Joanna Briggs Institute methodology. RESULTS: Eighteen articles were included. The two- and five-year survival rates of the patients were 52 per cent and 30 per cent respectively. CONCLUSION: Improvements in treatment modalities for recurrent oropharyngeal squamous cell carcinoma were associated with improvements in two-year overall survival rates, with minimal change to five-year overall survival rates. Various factors were identified as being associated with long-term overall survival, thus assisting clinicians in patient counselling and selection for salvage surgery.


Asunto(s)
Carcinoma de Células Escamosas/cirugía , Recurrencia Local de Neoplasia/cirugía , Neoplasias Orofaríngeas/cirugía , Terapia Recuperativa/mortalidad , Carcinoma de Células Escamosas/mortalidad , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/terapia , Quimioradioterapia Adyuvante/métodos , Supervivencia sin Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/mortalidad , Recurrencia Local de Neoplasia/patología , Recurrencia Local de Neoplasia/terapia , Estadificación de Neoplasias , Neoplasias Orofaríngeas/mortalidad , Neoplasias Orofaríngeas/patología , Neoplasias Orofaríngeas/terapia , Complicaciones Posoperatorias , Análisis de Supervivencia , Resultado del Tratamiento
6.
J Laryngol Otol ; 132(4): 349-355, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28480836

RESUMEN

BACKGROUND: The incidence of oropharyngeal squamous cell carcinoma in the Western world is increasing, with the human papillomavirus epidemic implicated in this observed trend. The optimal treatment modality is yet undetermined regarding oncological outcomes. METHODS: This study comprised 98 patients with oropharyngeal squamous cell carcinoma, treated with either primary transoral surgery with adjuvant therapy or primary chemoradiotherapy with curative intent, between 2008 and 2012. Clinicopathological characteristics including tumour-node-metastasis stage, human papillomavirus status, treatment modality, recurrence and overall survival were collated. RESULTS: Five per cent of primary surgical patients had locoregional recurrences compared with 25 per cent of primary chemoradiotherapy patients. A lower rate of locoregional recurrence was observed in the human papillomavirus positive group. CONCLUSION: This paper reports higher rates of overall survival and local control for oropharyngeal squamous cell carcinoma treated with primary surgery compared with primary chemoradiotherapy. This reflects overall lower tumour stage and higher human papillomavirus status in this group.


Asunto(s)
Carcinoma de Células Escamosas/cirugía , Protocolos Clínicos/normas , Neoplasias de Cabeza y Cuello/cirugía , Neoplasias Orofaríngeas/cirugía , Anciano , Australia/epidemiología , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/terapia , Carcinoma de Células Escamosas/virología , Quimioradioterapia Adyuvante/métodos , Inhibidor p16 de la Quinasa Dependiente de Ciclina , Supervivencia sin Enfermedad , Femenino , Neoplasias de Cabeza y Cuello/patología , Neoplasias de Cabeza y Cuello/terapia , Neoplasias de Cabeza y Cuello/virología , Papillomavirus Humano 16 , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Neoplasias Orofaríngeas/patología , Neoplasias Orofaríngeas/terapia , Neoplasias Orofaríngeas/virología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/epidemiología , Infecciones por Papillomavirus/patología , Estudios Retrospectivos , Procedimientos Quirúrgicos Robotizados/métodos , Carcinoma de Células Escamosas de Cabeza y Cuello , Resultado del Tratamiento
7.
J Laryngol Otol ; 132(2): 173-179, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28720161

RESUMEN

BACKGROUND: Appropriate selection of tongue cancer patients considering surgery is critical in ensuring optimal outcomes. The American College of Surgeons' National Surgical Quality Improvement Program ('ACS-NSQIP') risk calculator was developed to assess patients' 30-day post-operative risk, providing surgeons with information to guide decision making. METHOD: A retrospective review of 30-day actual mortality and morbidity of tongue cancer patients was undertaken to investigate the validity of this tool for South Australian patients treated from 2005 to 2015. RESULTS: One hundred and twenty patients had undergone glossectomy. Predicted length of stay using the risk calculator was significantly different from actual length of stay. Predicted mortality and other complications were found to be similar to actual outcomes. CONCLUSION: The American College of Surgeons' National Surgical Quality Improvement Program risk calculator was found to be effective in predicting post-operative complication rates in South Australian tongue cancer patients. However, significant discrepancies in predicted and actual length of stay may limit its use in this population.


Asunto(s)
Cirugía General , Glosectomía , Tiempo de Internación , Selección de Paciente , Mejoramiento de la Calidad , Colgajos Quirúrgicos , Neoplasias de la Lengua/cirugía , Anciano , Femenino , Glosectomía/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Procedimientos de Cirugía Plástica , Reproducibilidad de los Resultados , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Sociedades Médicas , Australia del Sur , Neoplasias de la Lengua/diagnóstico , Neoplasias de la Lengua/mortalidad , Resultado del Tratamiento , Estados Unidos
8.
J Laryngol Otol ; 132(10): 901-905, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30289089

RESUMEN

BACKGROUND: The role of panendoscopy in the modern investigation of head and neck cancer is changing with the development of improved radiological techniques, in-office biopsy capabilities and the low rate of synchronous primary tumours. This study aimed to review the indications for panendoscopy in the investigation of newly diagnosed head and neck cancer. METHOD: A retrospective review was conducted of 186 patients with newly diagnosed head and neck cancer, between January 2014 and December 2015, at two tertiary centres. RESULTS: Obtaining a tissue diagnosis was the most common indication for panendoscopy (65 per cent), followed by surgical planning including transoral robotic surgery suitability assessment (22.6 per cent), and the investigation of carcinoma of an unknown primary (11.3 per cent). Two synchronous primary tumours were identified, generating a yield of 1.1 per cent. CONCLUSION: Panendoscopy remains integral in the assessment of transoral robotic surgery suitability. Refining indications for modern panendoscopy could reduce the need for this procedure in this cohort of patients.


Asunto(s)
Broncoscopía , Carcinoma de Células Escamosas/diagnóstico , Esofagoscopía , Neoplasias de Cabeza y Cuello/diagnóstico , Consumo de Bebidas Alcohólicas/efectos adversos , Australia , Broncoscopía/métodos , Carcinoma de Células Escamosas/cirugía , Diagnóstico Diferencial , Esofagoscopía/métodos , Femenino , Neoplasias de Cabeza y Cuello/cirugía , Hospitales Universitarios , Humanos , Masculino , Boca , Cavidad Nasal , Cirugía Endoscópica por Orificios Naturales/métodos , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Sensibilidad y Especificidad , Fumar/efectos adversos
9.
QJM ; 108(10): 781-7, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25636343

RESUMEN

BACKGROUND: Long-staying medical inpatients carry a significant burden of acute and chronic illness. Prediction of their in-hospital and longer-term mortality risk is important. AIM: The aim of this study was to determine to what extent creatinine variability predicts in-hospital and 1-year mortality in inpatients. DESIGN: Retrospective cohort analysis. METHODS: Patients were included if aged 18 years or older and if admitted for 7 days or longer. The main outcome variables were mortality in hospital and after discharge. RESULTS: Increasing age, the presence of heart failure and a reduced estimated glomerular filtration rate (eGFR) on admission (<60 ml/min/1.73 m(2)) all associated with death risk (both in hospital and within a year of discharge). The creatinine change was related to mortality risk for the patient whilst in hospital and within 1 year after discharge independently of these other factors. The threshold of creatinine change, above which the in-hospital mortality rose significantly was 25 µmol/l (P < 0.001). A creatinine change of >10 µmol/l predicted significantly higher mortality within a year of discharge (P < 0.001). Every 5 µmol/l change in creatinine was associated with an in-hospital mortality increase of 3% (P < 0.001) and a 1-year mortality increase of 1% (P < 0.007). CONCLUSIONS: Patients with a creatinine rise or fall of >10 µmol/l during admission are at higher risk of death after discharge than those with more stable creatinine. These patients therefore merit further attention that might include more focused nutritional assessment, cardiovascular risk factor management or advance care planning.


Asunto(s)
Creatinina/sangre , Insuficiencia Cardíaca/sangre , Mortalidad Hospitalaria , Pacientes Internos/estadística & datos numéricos , Alta del Paciente/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo
10.
Plant Cell Rep ; 16(10): 696-699, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30727621

RESUMEN

A sweet potato (Ipomoea batatas cv. Tainong 57) trypsin inhibitor gene was introduced into tobacco plants (Nicotiana tabaccum cv. W38) by Agrobacterium tumefaciens- mediated transformation. From 30 independent transformants, three lines with high level of expression were further analyzed. The trypsin inhibitor gene, under control of the 35S CaMV promoter, led to the production of the trypsin inhibitor proteins up to 0.2% of the total protein. In insecticidal bioassays of transgenic tobacco plants, larval, growth of Spodoptera litura (F.), the tobacco cutworm, was severely retarded as compared to their growth on control plants. This observation implied that expression of sweet potato trypsin inhibitor can provide an efficient method for crop protection.

12.
Appl Environ Microbiol ; 60(7): 2415-20, 1994 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16349324

RESUMEN

Using PCR with a set of specific oligonucleotide primers to detect cryI-type genes, we were able to screen the cry-type genes of 225 Bacillus thuringiensis soil isolates from Taiwan without much cost in time or labor. Some combinations of cry genes (the cry-type profile) in a single isolate were unique. We identified five distinct profiles of crystal genes from the B. thuringiensis soil isolates from Taiwan. The cry genes included cryIA(a), cryIA(b), cryIA(c), cryIC, cryID, and cryIV. Interestingly, 501 B. thuringiensis isolates (93.5% of the total number that we identified) were isolated from areas at high altitudes. The profiles of cry-type genes were distinct in all isolation areas. The distribution of cry-type genes of our isolates therefore depended on geography. Using PCR footprinting to detect cryIC-type genes, we identified two distinct cryIC footprints from some of our isolates, indicating that these isolates may contain novel cryIC-type genes. B. thuringiensis isolates containing cryIA(a)-, cryIA(b)-, and cryIA(c)-type genes exhibited much greater activity against Plutella xylostella than did other isolates, indicating that multiple cry-type genes may be used as markers for the prediction of insecticidal activities.

13.
Curr Microbiol ; 40(4): 227-32, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10688690

RESUMEN

With PCR products as probes, we have cloned two new cry-type genes from Bacillus thuringiensis subsp. wuhanensis. The deduced amino acid sequence of the first clone is 77.3% identical to Cry1Ga1. The deduced protein sequence of the second clone is 69.8-78.7% identical to that of Cry1B group. The nomenclature assignment of these two clones is, therefore, named Cry1Gb1 and Cry1Bd1, respectively. The Cry1Bd1 is toxic to Plutella xylostella larvae, and the Cry1Gb1 is toxic to Pieris rapae larvae.


Asunto(s)
Bacillus thuringiensis/genética , Proteínas Bacterianas/genética , Toxinas Bacterianas , Genes Bacterianos , Toxinas Biológicas/genética , Secuencia de Aminoácidos , Animales , Bacillus thuringiensis/química , Proteínas Bacterianas/toxicidad , Secuencia de Bases , Mariposas Diurnas/efectos de los fármacos , Clonación Molecular , Larva/efectos de los fármacos , Dosificación Letal Mediana , Datos de Secuencia Molecular , Mariposas Nocturnas/efectos de los fármacos , Reacción en Cadena de la Polimerasa , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Toxinas Biológicas/toxicidad
14.
J Comput Assist Tomogr ; 13(3): 508-10, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2723186

RESUMEN

Chordomas derive from persistent nests of notochordal cells that do not regress. They usually arise from the midline within bone of the skull base or spinal column. Typical radiographic findings of chordomas include midline location and bony destruction. We report an unusual epidural chordoma of the lumbar spine.


Asunto(s)
Cordoma/diagnóstico , Neoplasias Epidurales/diagnóstico , Imagen por Resonancia Magnética , Adolescente , Humanos , Región Lumbosacra , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA